Two cases of plasma cell leukemia with atypical immunophenotype

被引：5

作者：

Buda, Gabriele ^{[1
]}

Carulli, Giovanni ^{[1
]}

Orciuolo, Enrico ^{[1
]}

Cannizzo, Elisa ^{[1
]}

Zucca, Alessandra ^{[1
]}

Azzara, Antonio ^{[1
]}

Rossi, Angela ^{[1
]}

Galimberti, Sara ^{[1
]}

Cecconi, Nadia ^{[1
]}

Petrini, Mario ^{[1
]}

机构：

[1] Pisa Univ, Sect Hematol, Dept Oncol Transplants & Adv Technol, IT-56100 Pisa, Italy

来源：

ACTA HAEMATOLOGICA | 2007年 / 118卷 / 01期

关键词：

D O I：

10.1159/000101557

中图分类号：

R5 [内科学];

学科分类号：

1002 [临床医学]; 100201 [内科学];

摘要：

[No abstract available]

引用

收藏

页码：27 / 29

页数：3

相关论文

共 15 条

[1]

VAD combination chemotherapy followed by bortezomib may be an effective treatment in secondary plasma cell leukemia [J].

Ataergin, Selmin ;

Arpaci, Fikret ;

Kaya, Ayper ;

Kaya, Turker ;

Gunhan, Omer .

AMERICAN JOURNAL OF HEMATOLOGY, 2006, 81 (12) :987-988

[2]

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma [J].

Child, JA ;

Morgan, GJ ;

Davies, FE ;

Owen, RG ;

Bell, SE ;

Hawkins, K ;

Brown, J ;

Drayson, MT ;

Selby, PJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (19) :1875-1883

[3]

Dose escalation therapy in previously untreated patients with multiple myeloma following Z-Dex induction treatment [J].

Clark, AD ;

Douglas, KW ;

Mitchell, LD ;

McQuaker, IG ;

Parker, AN ;

Tansey, PJ ;

Franklin, IM ;

Cook, G .

BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (03) :605-612

[4]

Bortezomib is effective in primary plasma cell leukemia [J].

Finnegan, Damian P. J. ;

Kettle, Paul ;

Drake, Mary ;

Matthews, Christine ;

Alexander, H. Denis ;

Popat, Rakesh ;

Cavanagh, Jamie D. ;

Wachsman, William ;

Morris, T. C. M. .

LEUKEMIA & LYMPHOMA, 2006, 47 (08) :1670-1673

[5]

Primary plasma cell leukemia:: Clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics [J].

García-Sanz, R ;

Orfao, A ;

González, M ;

Tabernero, MD ;

Bladé, J ;

Moro, MJ ;

Fernández-Calvo, J ;

Sanz, MA ;

Pérez-Simón, JA ;

Rasillo, A ;

San Miguel, JF .

BLOOD, 1999, 93 (03) :1032-1037

[6]

Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation [J].

Gemmel, C ;

Cremer, FW ;

Weis, M ;

Witzens, M ;

Moldenhauer, G ;

Koniczek, KH ;

Imbach, U ;

Ho, AD ;

Moos, M ;

Goldschmidt, H .

ANNALS OF HEMATOLOGY, 2002, 81 (02) :119-123

[7]

Plasma cell leukemia:: a rare condition [J].

Jiménez-Zepeda, VH ;

Domínguez, VJ .

ANNALS OF HEMATOLOGY, 2006, 85 (04) :263-267

[8]

Johnson Malisha R, 2006, Ann Diagn Pathol, V10, P263, DOI 10.1016/j.anndiagpath.2005.12.011

[9]

Successful treatment of multi-agent chemotherapy with rituximab for IgM plasma cell leukemia [J].

Oka, Satoko ;

Yokote, Taiji ;

Akioka, Toshikazu ;

Hara, Satoshi ;

Yamano, Takeshi ;

Tsuji, Motomu ;

Hanafusa, Toshiaki .

LEUKEMIA RESEARCH, 2006, 30 (12) :1581-1583

[10]

Multiple myeloma: Diagnosis and treatment [J].

Rajkumar, SV ;

Kyle, RA .

MAYO CLINIC PROCEEDINGS, 2005, 80 (10) :1371-1382